INNERVATE RADIOPHARMACEUTICALS Trademark
Trademark Overview
On Monday, March 3, 2025, a trademark application was filed for INNERVATE RADIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INNERVATE RADIOPHARMACEUTICALS trademark a serial number of 99064464. The federal status of this trademark filing is EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED as of Tuesday, August 5, 2025. This trademark is owned by INNERVATE RADIOPHARMACEUTICALS LLC. The INNERVATE RADIOPHARMACEUTICALS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
Contract manufacturing in the field of active pharmaceutical ingredients and radiopharmaceuticals
General Information
| Serial Number | 99064464 |
| Word Mark | INNERVATE RADIOPHARMACEUTICALS |
| Filing Date | Monday, March 3, 2025 |
| Status | 656 - EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED |
| Status Date | Tuesday, August 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer |
| Goods and Services | Contract manufacturing in the field of active pharmaceutical ingredients and radiopharmaceuticals |
| NOT AVAILABLE | "RADIOPHARMACEUTICALS" |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 3, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
Trademark Owner History
| Party Name | INNERVATE RADIOPHARMACEUTICALS LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Englewood, NJ 07631 |
Trademark Events
| Event Date | Event Description |
| Monday, March 3, 2025 | NEW APPLICATION ENTERED |
| Monday, March 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 5, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, August 5, 2025 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, August 5, 2025 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, August 5, 2025 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, August 5, 2025 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Monday, November 3, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, November 3, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
